As the EU revises an annex to its GMP guideline that outlines expectations for sterile drug manufacturing, a key official backs plans to retain a requirement in the annex for pre-use/post-sterilization integrity testing (PUPSIT) despite continued opposition from industry.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?